Lundbeckfond Invest A/S 13D and 13G filings for Lexeo Therapeutics, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 5:49 pm Sale |
2024-09-30 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
Lundbeckfond Invest A/S | 942,671 2.900% |
-893,288 (-48.66%) |
Filing |
| 2024-02-14 4:34 pm Purchase |
2023-12-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
Lundbeckfond Invest A/S | 1,835,959 6.900% |
1,835,959 (New Position) |
Filing |